Binding characteristics of pro-insulin-like growth factor-II from cancer patients: Binary and ternary complex formation with IGF binding proteins-1 to -6

Journal of Endocrinology

Volumn 165, Issue 2, 2000, Pages 253-260

  Bond, J J ^a,b   Meka, S ^a   Baxter, R C ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Coop Res Ctr for Diagn Technol ^*  (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0034087953     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1650253     Document Type: Article

References (35)

1. Baxter RC 1990 Radioimmunoassay for insulin-like growth factor (IGF)-II: interference by pure IGF-binding proteins. Journal of Immunoassay 11 445-458.
2. Baxter RC 1991 Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatrica (Suppl) 372 107-114.
3. Baxter RC 1996 The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia. Hormone Research 46 195-201.
4. Baxter RC & Martin JL 1986 Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. Journal of Clinical Investigation 78 1504-1512.
5. Baxter RC, Martin JL & Wood MH 1987 Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. Journal of Clinical Endocrinology and Metabolism 65 423-431.
6. Baxter RC, Martin JL & Beniac VA 1989 High molecular weight insulin-like growth factor binding protein complex: purification and properties of the acid-labile subunit from human serum. Journal of Biological Chemistry 264 11843-11848.
7. Baxter RC, Holman SR, Corbould A, Stranks S, Ho PJ & Braund W 1995 Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in non-islet cell tumor hypoglycemia. Journal of Clinical Endocrinology and Metabolism 80 2700-2708.
8. Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M & Rotwein P 1988 Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. New England Journal of Medicine 319 1434-1440.
9. Daughaday WH & Kapadia M 1989 Significance of abnormal serum binding of insulin-like growth factor-II in the development of hypoglycemia in patients with non-islet cell tumours. Proceedings of the National Academy of Sciences of the USA B6 6778-6782.
10. Daughaday WH, Tnvedi B & Baxter RC 1993 Serum 'big insulin-like growth factor-II' from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of propeptide processing. Proceedings of the National Academy af Sciences of the USA 90 5823-5827.
11. Daughaday WH, Trivedi B & Baxter RC 1995 Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid-labile subunit and leads to elevation of serum free IGF-II. Endocrine 3 425-428.
12. Duguay SJ, Jin Y, Stem J, Duguay AN, Gardener P & Sterner DF 1998 Post-translational processing of the insulin-like growth factor-II precursor. Journal of Biological Chemistry 273 18443-18451.
13. Firth SM, Ganeshprasad U & Baxter RC 1998 Structural determinants of the ligand and cell surface binding of insulin-like growth factor binding protein-3 Journal of Biological Chemistry 273 2631-2638.
14. Firth SM, Ganeshprasad U, Poronnik P, Cook DI & Baxter RC 1999 Adenoviral-mediated expression of human insulin-like growth factor-binding protein-3. Protein Expression and Purification 16 202-211.
15. Gelato MC & Vassalotti J 1990 Insulin-like growth factor-II: possible local growth factor in pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 71 1168-1174.
16. Gowan LK, Hampton B, Hill DJ, Schlueter RJ & Perdue JF 1987 Purification and characterisation of a unique high molecular weight form of insulin-like growth factor-II. Endocrinology 121 449-458.
17. Gray A, Tam AW, Dull TJ, Hayflick J, Pintar J, Cavenee WK, Koufos A & Ullrich A 1987 Tissue-specific and developmentally regulated transcription of the insulin-like growth factor 2 gene. DNA 6 283-295.
18. Hizuka N, Fukuda I, Takano K, Asakawa-Yasumoto K, Okubo Y & Demura H 1998 Serum high molecular weight form of insulin-like growth factor-II from patients with non-islet cell tumor hypoglycemia is O-glycosylated. Journal of Clinical Endocrinology and Metabolism 83 2875-2877.
19. Ho PJ & Baxter RC 1997 Characterization of truncated insulin-like growth factor-binding protein-2 in human nulk. Endocrinology 138 3811-3818.
20. Hodzic D, Delacroix L, Willemsen Ph, Bensbaho K, Collette J. Broux R, Lefebvre P, Legros JJ, Grooteclaes M & Winkler R 1997 Characterisation of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in mesothelioma. Hormone and Metabolic Research 29 549-555.
21. Horiuchi T, Shinohara Y, Sakamoto Y, Hizuka N, Watabe T, Mokuda O, Tanaka K, Shimizu N, Sugano I & Nagao K 1994 Expression of insulin-like growth factor-II by a gastric carcinoma associated with hypoglycemia. Virchows Archiv 424 449-452.
22. Hudgins RW, Hampton B, Burgess WH & Perdue JF 1992 The identification of O-glycosylated precursors of insulin-like growth factor-II. journal of Biological Chemistry 267 8153-8160.
23. Jones JI & Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16 3-34.
24. Liu F, Baker BK, Powell DR & Hintz RL 1993 Characterisation of proinsuhn-like growth factor-II E-region immunoreactivity in serum and other biological fluids. Journal of Clinical Endocrinology and Metabolism 76 1095-1100.
25. Martin JL & Baxter RC 1986 Insulin-like growth factor-binding protein from human plasma. Purification and characterization. Journal of Biological Chemistry 261 8754-8760.
26. Martin JL, Willetts KE & Baxter RC 1990 Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. Journal of Biological Chemistry 265 4124-4130.
27. Ono T, Kanzaki S, Seino Y, Baylink DJ & Mohan S 1996 Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein -3 and -5, and bone alkaline phosphatase isoenzyme. Journal of Clinical Endocrinology and Metabolism 81 2111-2116.
28. Reeve AE, Eccles MR, Wilkms RJ, Bell GI & Millow LJ 1985 Expression of insulin-like growth factor-II transcripts in Wilm's tumour. Nature 317 258-260.
29. Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Kall LB, Graham CF & Knott TJ 1985 Insulin-like growth factor-II gene expression in Wilm's tumour and embryonic tissues. Nature 317 260-262.
30. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT & Cullen KJ 1995 Malignant breast epithelium selects for insulin-like growth factor-II expression in breast stroma: evidence for paracrine function. Cancer Research 55 2448-2454.
31. Sussenbach JS, Steenberg PH & de Pagter Holthuizen P 1992 Structure and expression of the human insulin-like growth factor genes. Growth Regulation 2 1-9.
32. Twigg SM & Baxter RC 1998 Insulin-like growth factor (IGF)-binding protem-5 forms an alternative ternary complex with IGFs and the acid labile subunit. Journal of Biological Chemistry 273 6074-6079.
33. Twigg SM, Kiefer MC, Zapf J & Baxter RC 1998 Insulin-like growth factor binding protein-5 complexes with the acid labile subunit: role of the carboxyl-terminal domain. Journal of Biological Chemistry 273 28791-28798.
34. Van der Ven LTM, Roholl PJM, Gloudenians T, Van Buul-Offers SC, Welters MJP, Bladergroen BA, Faber JAJ. Sussenbach JS & Den Otter W 1997 Expression of insulin-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues. Journal of Cancer 75 1631-1640.
35. Zumstein PP, Luthi C & Humbel RE 1985 Amino acid sequence of a variant proform of insulin-like growth factor-II. Proceedings of the National Academy of Sciences of the USA 82 3169-3172.